Sign inJoin waitlistJoin the waitlist

Ann Dahlberg

Associate Program Director · University of Washington School of Medicine

Credentials: · ·

History

University of Washington School of Medicine
Present
Pediatric Outpatient Transplant Clinic · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

University of Washington School of Medicine
2008–2011
Pediatrics
University of Washington School of Medicine
2005–2008
Harvard Medical School
2001–2005
Stanford University, Stanford, CA, BS
1997–2001

Research

Cord-Blood Transplantation in Patients with Minimal Residual Disease
New England Journal of Medicine · 2016 · 380 citations
Ex vivo expansion of human hematopoietic stem and progenitor cells
Review · Blood · 2011 · First of 3 authors · 208 citations
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease
Journal of Clinical Oncology · 2022 · 96 citations

Filippo Milano
15 papers · 9 as a resident
Colleen Delaney
13 papers · 2 as a fellow
Corinne Summers
10 papers
Marie Bleakley
9 papers
Paul Carpenter
9 papers
Rachel Salit
6 papers
Irwin Bernstein
5 papers
Lauri Burroughs
5 papers
Monica Thakar
5 papers
Brandon Hadland
4 papers
Katherine Tarlock
4 papers
Neel Bhatt
4 papers

Clinical trials

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Principal investigator · Recruiting · Phase 2
Fred Hutchinson Cancer Center
2024–2032
Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 1
Nohla Therapeutics, Inc.
2012–2018
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2005–2024
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Site PI · Recruiting · Phase 2
New York Blood Center
2012–2030